Robert Axtell to Interferon-beta
This is a "connection" page, showing publications Robert Axtell has written about Interferon-beta.
Connection Strength
3.437
-
Interferon-ß Intensifies Interleukin-23-Driven Pathogenicity of T Helper Cells in Neuroinflammatory Disease. Cells. 2021 08 20; 10(8).
Score: 0.760
-
B cell function impacts the efficacy of IFN-ß therapy in EAE. J Neuroimmunol. 2020 01 15; 338:577106.
Score: 0.672
-
IFN-ß treatment requires B cells for efficacy in neuroautoimmunity. J Immunol. 2015 Mar 01; 194(5):2110-6.
Score: 0.483
-
Interferon-ß exacerbates Th17-mediated inflammatory disease. Trends Immunol. 2011 Jun; 32(6):272-7.
Score: 0.372
-
T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med. 2010 Apr; 16(4):406-12.
Score: 0.345
-
Type 1 interferons cool the inflamed brain. Immunity. 2008 May; 28(5):600-2.
Score: 0.302
-
Interleukin 17F level and interferon ß response in patients with multiple sclerosis. JAMA Neurol. 2013 Aug; 70(8):1017-21.
Score: 0.109
-
Janus-like effects of type I interferon in autoimmune diseases. Immunol Rev. 2012 Jul; 248(1):23-35.
Score: 0.101
-
Serum IL-17F does not predict poor response to IM IFNß-1a in relapsing-remitting MS. Neurology. 2012 Aug 07; 79(6):531-7.
Score: 0.100
-
Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein. Mult Scler. 2012 Apr; 18(4):398-408.
Score: 0.098
-
IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-ß in multiple sclerosis. Sci Transl Med. 2011 Jul 27; 3(93):93ra68.
Score: 0.095